Biotechnology Ultrasector Profund Fund Quote
| BIPIX Fund | USD 43.28 0.33 0.76% |
PerformanceFair
| Odds Of DistressLow
|
Biotechnology Ultrasector is trading at 43.28 as of the 31st of August 2025; that is 0.76 percent down since the beginning of the trading day. The fund's open price was 43.61. Biotechnology Ultrasector has about a 20 % chance of experiencing some form of financial distress in the next two years of operation and did not have a very good performance during the last 90 trading days. The performance scores are derived for the period starting the 1st of August 2025 and ending today, the 31st of August 2025. Click here to learn more.
The index is designed to measure the performance of biotechnology companies included in the SP Total Market Index. Under normal circumstances, the fund will obtain leveraged exposure to at least 80 percent of its total assets in components of the index or in instruments with similar economic characteristics. More on Biotechnology Ultrasector Profund
Moving together with Biotechnology Mutual Fund
| 0.8 | TEPIX | Technology Ultrasector | PairCorr |
| 0.8 | TEPSX | Technology Ultrasector | PairCorr |
| 0.83 | LGPIX | Large Cap Growth | PairCorr |
Moving against Biotechnology Mutual Fund
Biotechnology Mutual Fund Highlights
| Thematic Idea | Tech Funds (View all Themes) |
| Fund Concentration | ProFunds Funds, Large Funds, Trading--Leveraged Equity Funds, Tech Funds, Trading--Leveraged Equity, ProFunds, Large Blend, Trading--Leveraged Equity (View all Sectors) |
| Update Date | 30th of June 2025 |
| Expense Ratio Date | 30th of November 2022 |
| Fiscal Year End | July |
Biotechnology Ultrasector Profund [BIPIX] is traded in USA and was established 31st of August 2025. Biotechnology Ultrasector is listed under ProFunds category by Fama And French industry classification. The fund is listed under Trading--Leveraged Equity category and is part of ProFunds family. The entity is thematically classified as Tech Funds. This fund currently has accumulated 116.96 M in assets under management (AUM) with minimum initial investment of 15 K. Biotechnology Ultrasector is currently producing year-to-date (YTD) return of 1.42% with the current yeild of 0.0%, while the total return for the last 3 years was -0.35%.
Check Biotechnology Ultrasector Probability Of Bankruptcy
Instrument Allocation
Sector Allocation
Investors will always prefer to have their portfolios divercified against different sectors. The broad sector allocation increases the possibility of making a profit or at least avoiding a loss. However, this may also reduce the expected return on Biotechnology Mutual Fund. Generally, it depends on diversification level and type but usually, the broader the sector allocation, the less risk can be expected from holding Biotechnology Mutual Fund, and the less return is expected.
Institutional investors that are interested in enforcing a sector tilt in their portfolio can use exchange-traded funds, such as Biotechnology Ultrasector Profund Mutual Fund, as a low-cost alternative to building a custom portfolio. So, using sector ETFs to diversify your portfolio can be a profitable strategy. However, no matter what sectors are desirable at a given time, no single industry should ever make up more than 20 percent of your stock portfolio.
Top Biotechnology Ultrasector Profund Mutual Fund Constituents
| BMRN | Biomarin Pharmaceutical | Stock | Health Care | |
| A | Agilent Technologies | Stock | Health Care | |
| ABBV | AbbVie Inc | Stock | Health Care | |
| AMGN | Amgen Inc | Stock | Health Care | |
| BIIB | Biogen Inc | Stock | Health Care | |
| GILD | Gilead Sciences | Stock | Health Care | |
| ILMN | Illumina | Stock | Health Care | |
| IQV | IQVIA Holdings | Stock | Health Care |
Biotechnology Ultrasector Risk Profiles
| Mean Deviation | 1.53 | |||
| Semi Deviation | 1.51 | |||
| Standard Deviation | 1.97 | |||
| Variance | 3.88 |
Biotechnology Ultrasector Against Markets
Other Information on Investing in Biotechnology Mutual Fund
Biotechnology Ultrasector financial ratios help investors to determine whether Biotechnology Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biotechnology with respect to the benefits of owning Biotechnology Ultrasector security.
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |